CN1203891C - 治疗冠心病的药物及制备方法 - Google Patents
治疗冠心病的药物及制备方法 Download PDFInfo
- Publication number
- CN1203891C CN1203891C CN 200310103981 CN200310103981A CN1203891C CN 1203891 C CN1203891 C CN 1203891C CN 200310103981 CN200310103981 CN 200310103981 CN 200310103981 A CN200310103981 A CN 200310103981A CN 1203891 C CN1203891 C CN 1203891C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix salviae
- salviae miltiorrhizae
- extractum
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 68
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 229940079593 drug Drugs 0.000 title description 14
- 239000002994 raw material Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 12
- 238000002481 ethanol extraction Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 241000725145 Homalomena Species 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 19
- 206010021143 Hypoxia Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007954 hypoxia Effects 0.000 description 5
- 241000219295 Portulaca Species 0.000 description 4
- 241001404789 Smilax glabra Species 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000002242 deionisation method Methods 0.000 description 4
- 208000028867 ischemia Diseases 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol hydrochloride Natural products C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- IROWCYIEJAOFOW-UHFFFAOYSA-N DL-Isoprenaline hydrochloride Chemical compound Cl.CC(C)NCC(O)C1=CC=C(O)C(O)=C1 IROWCYIEJAOFOW-UHFFFAOYSA-N 0.000 description 2
- HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 229960003627 gemfibrozil Drugs 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940039009 isoproterenol Drugs 0.000 description 2
- 229940018448 isoproterenol hydrochloride Drugs 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- MEAPRSDUXBHXGD-UHFFFAOYSA-N 3-chloro-n-(4-propan-2-ylphenyl)propanamide Chemical compound CC(C)C1=CC=C(NC(=O)CCCl)C=C1 MEAPRSDUXBHXGD-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 229960004604 propranolol hydrochloride Drugs 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310103981 CN1203891C (zh) | 2003-10-28 | 2003-10-28 | 治疗冠心病的药物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310103981 CN1203891C (zh) | 2003-10-28 | 2003-10-28 | 治疗冠心病的药物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1517122A CN1517122A (zh) | 2004-08-04 |
CN1203891C true CN1203891C (zh) | 2005-06-01 |
Family
ID=34304254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310103981 Expired - Lifetime CN1203891C (zh) | 2003-10-28 | 2003-10-28 | 治疗冠心病的药物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1203891C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101912491B (zh) * | 2010-07-27 | 2012-05-02 | 云南名扬药业有限公司 | 治疗心血管疾病的滴丸剂及制备方法 |
CN102526189B (zh) * | 2012-02-20 | 2013-08-07 | 崔新明 | 一种治疗冠心病心绞痛的中药组合物 |
CN116173141A (zh) * | 2022-11-24 | 2023-05-30 | 深圳先进技术研究院 | 一种中药组合物、心律失常治疗敷贴及其制备方法 |
-
2003
- 2003-10-28 CN CN 200310103981 patent/CN1203891C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1517122A (zh) | 2004-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1742939A (zh) | 一种治疗肺间质纤维化的药物及其制备方法 | |
CN1840166A (zh) | 温胆汤现代中药口服制剂及其生产方法 | |
CN1723981A (zh) | 罗汉果提取物用于制备药物辅料的新用途 | |
CN1210047C (zh) | 治疗感冒的药物及其制备方法 | |
CN1806821A (zh) | 一种治疗鼻炎的药物 | |
CN1203891C (zh) | 治疗冠心病的药物及制备方法 | |
CN1724014A (zh) | 威灵仙总皂苷提取物、其制备方法及其在制备药物中的用途 | |
CN1927279A (zh) | 一种用于皮肤病的中药组合物 | |
CN1709415A (zh) | 石刁柏提取物及其制备方法 | |
CN1692938A (zh) | 一种用于明目的中药复方制剂及其制备方法 | |
CN104095940B (zh) | 一种治疗痛风的中药组合物 | |
CN1302792C (zh) | 一种具有解酒保肝作用的药物组合物及其用途 | |
CN1927289A (zh) | 一种治疗糖尿病及糖耐量低减的药物组合物及制备方法 | |
CN1803155A (zh) | 一种治疗鼻炎的药物 | |
CN1212150C (zh) | 治疗病毒性肝炎的药物及制备方法 | |
CN106728347B (zh) | 一种风湿液及其制备方法 | |
CN1240418C (zh) | 一种治疗胃脘痛的中药复方制剂及其制备方法 | |
CN1772149A (zh) | 一种治疗冠心病的中药组合物及其制备方法 | |
CN1853711A (zh) | 一种心脉康中药组合物及其制备方法 | |
CN1557824A (zh) | 蚕沙总生物碱及其制备方法 | |
CN1150918C (zh) | 珠子参有效成份制剂及制备方法 | |
CN1470271A (zh) | 一种治疗肝纤维化疾病的中药复方制剂及其制备方法 | |
CN109999155B (zh) | 治疗阿尔茨海默病的中药组合物及其制备方法 | |
CN100346816C (zh) | 一种用于预防和治疗流行性感冒的中药组合物 | |
CN1682939A (zh) | 治疗病毒性肝炎的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANG XU Free format text: FORMER OWNER: WEN XIANMIN Effective date: 20091106 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091106 Address after: No. 3, unit 1, building 4, friendship Street, Jianshe Road, Gansu, Jiayuguan Patentee after: Zhang Xu Address before: No. 14 Dongfeng Dongfeng Road, Panlong District, Yunnan, Kunming Patentee before: Wen Xianmin |
|
ASS | Succession or assignment of patent right |
Owner name: YUNNAN SUNSAIL PHARMACEUTICAL LTD. Free format text: FORMER OWNER: ZHANG XU Effective date: 20120109 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 735100 JIAYUGUAN, GANSU PROVINCE TO: 650051 KUNMING, YUNNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120109 Address after: 650051 first floor, No. 297, Qingnian Road, Yunnan, Kunming Patentee after: Yunnan Sunsail Pharmaceutical Co.,Ltd. Address before: 735100 No. 3, unit 4, building 1, friendship Street, Jianshe Road, Gansu, Jiayuguan Patentee before: Zhang Xu |
|
C35 | Partial or whole invalidation of patent or utility model | ||
IP01 | Partial invalidation of patent right |
Commission number: 4W02878 Conclusion of examination: Claim No. 200310103981.4 of the patent right for invention No. 3-4 and 7-8 is invalid, and the patent right of the invention is effectively maintained on the basis of claim 1-2 and 5-6 of the patent right announcement. Decision date of declaring invalidation: 20120427 Decision number of declaring invalidation: 18482 Denomination of invention: Medicine for treating coronary heart disease and its preparation method Granted publication date: 20050601 Patentee: Yunnan Sunsail Pharmaceutical Co.,Ltd.|Zhang Xu |
|
CX01 | Expiry of patent term |
Granted publication date: 20050601 |
|
CX01 | Expiry of patent term |